Methylhydrazine

Methylhydrazine

SCHEMBL631149

CNN.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Methylhydrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119269704-A Method for measuring methyl hydrazine content by pre-column derivatization-high performance liquid chromatography 湖北泰盛化工有限公司 2025-01-07 CN claimed
CN-116574028-B Preparation method of high-purity methyl hydrazine 北京航天凯恩新材料有限公司 2024-11-29 CN claimed
CN-116574028-A Preparation method of high-purity methyl hydrazine 北京航天凯恩新材料有限公司 2023-08-11 CN claimed
CN-115819346-A Synthetic method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-ethyl formate 湖南化工研究院有限公司 2023-03-21 CN claimed
CN-112480008-B Synthesis method of 1-methyl-5-hydroxypyrazole 浙江工业大学 2022-10-11 CN claimed
CN-112094210-A Preparation method of substituted sulfinate 江苏扬农化工股份有限公司 2020-12-18 CN claimed
CN-107098934-B A kind of method of phthalic aldehyde derivative phosphoramidite monomer, synthetic method and the quick coupling protein matter of DNA 厦门大学 2019-03-12 CN claimed
US-20150353501-A1 PROCESS FOR THE PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLATE AND ITS ANALOGS KingChem LLC. 2015-12-10 US claimed
EP-2951145-A1 PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ESTER Kingchem, LLC (US) 2015-12-09 EP claimed
US-9139507-B2 Process for the preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylate and its analogs KingChem LLC. (US) 2015-09-22 US claimed
WO-2015085464-A1 PROCESS FOR PREPARING ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLATE AND ITS ANALOGS KING CHEM, LLC (US) 2015-06-18 WO claimed
US-20150158808-A1 A PROCESS FOR THE PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLATE AND ITS ANALOGS KingChem LLC. 2015-06-11 US claimed
US-8957254-B2 Process for chemical synthesis from an alkenone made from a halogenated precursor SOLVAY SA (BE) 2015-02-17 US claimed
US-8871947-B2 Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester KingChem LLC (US) 2014-10-28 US claimed
CN-104105684-A Preparation of alkyl 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid ester KingChem LLC 2014-10-15 CN claimed
WO-2014120397-A1 PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ESTER KINGCHEM, LLC (US) 2014-08-07 WO claimed
US-20140221669-A1 PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ESTER KingChem LLC 2014-08-07 US claimed
US-20140051892-A1 Process for chemical synthesis from an alkenone made from a halogenated precursor SOLVAY SA (BE) 2014-02-20 US claimed
EP-1871753-B1 PREPARATION OF TAXANES FROM 9-DIHYDRO-13-ACETYLBACCATIN III ACCORD HEALTHCARE INC (CA) 2012-07-18 EP claimed
JP-1156963-A None JP disclosed
CN-119269704-A Method for measuring methyl hydrazine content by pre-column derivatization-high performance liquid chromatography 湖北泰盛化工有限公司 2025-01-07 CN disclosed
CN-119269704-A Method for measuring methyl hydrazine content by pre-column derivatization-high performance liquid chromatography 湖北泰盛化工有限公司 2025-01-07 CN disclosed
CN-119100988-A Preparation method of hydroxypyrazole derivative under action of alkali 山东京博农化科技股份有限公司 2024-12-10 CN disclosed
CN-116574028-B Preparation method of high-purity methyl hydrazine 北京航天凯恩新材料有限公司 2024-11-29 CN disclosed
CN-116574028-B Preparation method of high-purity methyl hydrazine 北京航天凯恩新材料有限公司 2024-11-29 CN disclosed
WO-2024119117-A1 MODIFIED 5' CAP FOR MRNA AND METHODS OF USE THEREOF PRIME MEDICINE, INC. (US) 2024-06-06 WO disclosed
CN-117919755-A Energy-saving system for methyl hydrazine concentration section by ammonia chloride method 营口福康精细化工科技有限公司 2024-04-26 CN disclosed
WO-2024069235-A2 COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS Sixfold Bioscience Ltd. (GB) 2024-04-04 WO disclosed
EP-4323517-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS Sixfold Bioscience Ltd. (GB) 2024-02-21 EP disclosed
CN-219579916-U Device for preparing high-purity methyl hydrazine 北京航天凯恩新材料有限公司 2023-08-25 CN disclosed
CN-116574028-A Preparation method of high-purity methyl hydrazine 北京航天凯恩新材料有限公司 2023-08-11 CN disclosed
CN-116574028-A Preparation method of high-purity methyl hydrazine 北京航天凯恩新材料有限公司 2023-08-11 CN disclosed
CN-115232023-B Process for catalytic synthesis of methyl hydrazine 东力(南通)化工有限公司 2023-08-04 CN disclosed
US-20230183746-A1 COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS Sixfold Bioscience Ltd. (GB) 2023-06-15 US disclosed
CN-115997016-A Composition comprising nucleic acid nanoparticles having modular functional groups 西克斯福德生物科学有限公司 2023-04-21 CN disclosed
CN-115819346-A Synthetic method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-ethyl formate 湖南化工研究院有限公司 2023-03-21 CN disclosed
CN-115819346-A Synthetic method of 3- (difluoromethyl) -1-methyl-1H-pyrazole-4-ethyl formate 湖南化工研究院有限公司 2023-03-21 CN disclosed
EP-4143316-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2023-03-08 EP disclosed
EP-4103577-A1 NOVEL MRNA 5'-END CAP ANALOGS, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE Uniwersytet Warszawski (PL) 2022-12-21 EP disclosed
CN-112939893-B Synthesis method of 4- (4-aminophenyl) -3-morpholinone 普济生物科技(台州)有限公司 2022-08-23 CN disclosed
EP-4022058-A2 COMPOSITIONS FOR TRANSFER OF CARGO TO CELLS Sixfold Bioscience Ltd. (GB) 2022-07-06 EP disclosed
US-11357865-B2 Compositions containing nucleic acid nanoparticles with modular functionality Sixfold Bioscience Ltd. (GB) 2022-06-14 US disclosed
US-11358937-B2 Reagents based on a tertiary amine backbone to introduce chemical functionality in nucleic acids and sequence-controlled polymers THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2022-06-14 US disclosed
CN-112441978-B Preparation method of 1-methyl-5-hydroxypyrazole-4-carboxylic acid ethyl ester 江西天宇化工有限公司 2022-04-26 CN disclosed
CN-114292208-A Method for preparing methylhydrazine by solid acid catalysis 杭州新本立医药有限公司 2022-04-08 CN disclosed
CN-112694448-B Process for the preparation of triazine rings 山东金城柯瑞化学有限公司 2022-02-22 CN disclosed
CN-113979944-A Synthesis method of high-selectivity 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol 杭州欧晨科技有限公司 2022-01-28 CN disclosed
CN-113979944-A Synthesis method of high-selectivity 1-methyl-3- (trifluoromethyl) -1H-pyrazole-5-alcohol 杭州欧晨科技有限公司 2022-01-28 CN disclosed
WO-2021220053-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2021-11-04 WO disclosed
US-20210330810-A1 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2021-10-28 US disclosed
US-20210324198-A1 SILICON-SUBSTITUTED RHODAMINE DYES AND DYE CONJUGATES Life Technologies Corporation 2021-10-21 US disclosed
WO-2021162567-A1 NOVEL MRNA 5'-END CAP ANALOGS, RNA MOLECULE INCORPORATING THE SAME, USES THEREOF AND METHOD OF SYNTHESIZING RNA MOLECULE OR PEPTIDE UNIWERSYTET WARSZAWSKI (PL) 2021-08-19 WO disclosed
WO-2021140636-A1 STRETCHABLE FILM 株式会社ダイセル 2021-07-15 WO disclosed
EP-3833673-A1 REAGENTS BASED ON A TERTIARY AMINE BACKBONE TO INTRODUCE CHEMICAL FUNCTIONALITY IN NUCLEIC ACIDS AND SEQUENCE-CONTROLLED POLYMERS The Royal Institution for the Advancement of Learning / McGill University (CA) 2021-06-16 EP disclosed
CN-112939893-A Synthesis method of 4- (4-aminophenyl) -3-morpholinone 普济生物科技(台州)有限公司 2021-06-11 CN disclosed
US-20210163422-A1 REAGENTS BASED ON A TERTIARY AMINE BACKBONE TO INTRODUCE CHEMICAL FUNCTIONALITY IN NUCLEIC ACIDS AND SEQUENCE-CONTROLLED POLYMERS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2021-06-03 US disclosed
CN-112566986-A Silicon-substituted rhodamine dyes and dye conjugates 生命技术公司 2021-03-26 CN disclosed
CN-112441978-A Preparation method of 1-methyl-5-hydroxypyrazole-4-carboxylic acid ethyl ester 江西天宇化工有限公司 2021-03-05 CN disclosed
CN-112094210-A Preparation method of substituted sulfinate 江苏扬农化工股份有限公司 2020-12-18 CN disclosed
US-10786582-B2 Gd(III)-dithiolane gold nanoparticle conjugates NORTHWESTERN UNIVERSITY (US) 2020-09-29 US disclosed
WO-2020142825-A1 REAGENTS BASED ON A TERTIARY AMINE BACKBONE TO INTRODUCE CHEMICAL FUNCTIONALITY IN NUCLEIC ACIDS AND SEQUENCE-CONTROLLED POLYMERS THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2020-07-16 WO disclosed
CN-107406373-B Boron-containing diacylhydrazine compounds 英特瑞克斯顿股份有限公司 2020-04-28 CN disclosed
EP-3194359-B1 BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS INTREXON CORP (US) 2020-04-08 EP disclosed
WO-2020053373-A1 NOVEL TRF1 MODULATORS AND ANALOGUES THEREOF Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) (ES) 2020-03-19 WO disclosed
EP-3623370-A1 NOVEL TRF1 MODULATORS AND ANALOGUES THEREOF Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) (ES) 2020-03-18 EP disclosed
US-10570158-B2 Boron-containing diacylhydrazine compounds INTREXON CORPORATION (US) 2020-02-25 US disclosed
US-10544146-B2 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors FEDORA PHARMACEUTICALS INC. (CA) 2020-01-28 US disclosed
US-20190321492-A1 Gd(III)-Dithiolane Gold Nanoparticle Conjugates NORTHWESTERN UNIVERSITY 2019-10-24 US disclosed
US-10406249-B2 Gd(III)-dithiolane gold nanoparticle conjugates NORTHWESTERN UNIVERSITY (US) 2019-09-10 US disclosed
CN-109574853-A For synthesizing method, catalyst and its application of amino benzenes compounds 普济生物科技(台州)有限公司 2019-04-05 CN disclosed
CN-109475531-A The heterocycle inhibitor of PTPN11 得克萨斯州立大学董事会 2019-03-15 CN disclosed
CN-107098934-B A kind of method of phthalic aldehyde derivative phosphoramidite monomer, synthetic method and the quick coupling protein matter of DNA 厦门大学 2019-03-12 CN disclosed
CN-109336921-A DNA base analog, purposes and its synthetic method 厦门大学 2019-02-15 CN disclosed
CN-109097032-A The preparation method of carbon quantum dot fluorescent material and its application in copper ion detection 上海大学 2018-12-28 CN disclosed
US-10125363-B2 Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types NLIFE THERAPEUTICS, S.L. (ES) 2018-11-13 US disclosed
EP-3398941-A1 HETEROCYCLIC P2X7 ANTAGONISTS AXXAM S.p.A. (IT) 2018-11-07 EP disclosed
US-20180305359-A1 BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETA-LACTAMASE INHIBITORS FEDORA PHARMACEUTICALS INC. (CA) 2018-10-25 US disclosed
CN-108682466-A A kind of oxidation unit and method of the feed liquid containing plutonium 中国原子能科学研究院 2018-10-19 CN disclosed
US-10030019-B2 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors FEDORA PHARMACEUTICALS INC. (CA) 2018-07-24 US disclosed
US-20180201628-A1 Boron-Containing Diacylhydrazine Compounds INTREXON CORP (US) 2018-07-19 US disclosed
CN-107980001-A Compounds and compositions comprising phosphorothioated oligodeoxynucleotides and methods of use thereof 希望之城 2018-05-01 CN disclosed
US-9944659-B2 Boron-containing diacylhydrazine compounds INTREXON CORPORATION (US) 2018-04-17 US disclosed
CN-106543026-B A kind of preparation method of methyl hydrazine 石家庄金派医药化工有限公司 2018-01-16 CN disclosed
CN-107406373-A Boron-containing diacylhydrazine compounds 英特瑞克斯顿股份有限公司 2017-11-28 CN disclosed
EP-3194359-A1 BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS Intrexon Corporation (US) 2017-07-26 EP disclosed
CN-106543026-A A kind of preparation method of methyl hydrazine 重庆锦杉科技有限公司 2017-03-29 CN disclosed
CN-104379551-B The preparation method of 3 difluoromethyl, 1 methyl 1H pyrazoles 4 alkyl carboxylates and the like 金凯有限责任公司 2017-03-08 CN disclosed
US-20160375154-A1 Gd(III)-Dithiolane Gold Nanoparticle Conjugates NORTHWESTERN UNIVERSITY 2016-12-29 US disclosed
US-9505761-B2 Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors FEDORA PHARMACEUTICALS INC. (CA) 2016-11-29 US disclosed
US-20160297817-A1 BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETA-LACTAMASE INHIBITORS FEDORA PHARMACEUTICALS INC. (CA) 2016-10-13 US disclosed
CN-105873930-A Novel bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors 费多拉制药公司 2016-08-17 CN disclosed
US-9393239-B2 Bicyclic compounds and their use as antibacterial agents and betalactamase inhibitors FEDORA PHARMACEUTICALS INC. (CA) 2016-07-19 US disclosed
WO-2016044390-A1 BORON-CONTAINING DIACYLHYDRAZINE COMPOUNDS INTREXON CORPORATION (US) 2016-03-24 WO disclosed
US-20160083726-A1 Compositions and Methods for the Treatment of Parkinson Disease by the Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types PALOMO LIMITED (CY) 2016-03-24 US disclosed
US-20160083403-A1 Boron-Containing Diacylhydrazine Compounds INTREXON CORPORATION 2016-03-24 US disclosed
US-20150353501-A1 PROCESS FOR THE PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLATE AND ITS ANALOGS KingChem LLC. 2015-12-10 US disclosed
EP-2951145-A1 PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ESTER Kingchem, LLC (US) 2015-12-09 EP disclosed
US-9193969-B2 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types NLIFE THERAPEUTICS, S.L. (ES) 2015-11-24 US disclosed
EP-2931723-A1 NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND -LACTAMASE INHIBITORS Fedora Pharmaceuticals Inc. (CA) 2015-10-21 EP disclosed
US-9139507-B2 Process for the preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylate and its analogs KingChem LLC. (US) 2015-09-22 US disclosed
US-9084825-B2 Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types NLIFE THERAPEUTICS, S.L. (ES) 2015-07-21 US disclosed
WO-2015085464-A1 PROCESS FOR PREPARING ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLATE AND ITS ANALOGS KING CHEM, LLC (US) 2015-06-18 WO disclosed
US-20150158808-A1 A PROCESS FOR THE PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLATE AND ITS ANALOGS KingChem LLC. 2015-06-11 US disclosed
US-8957254-B2 Process for chemical synthesis from an alkenone made from a halogenated precursor SOLVAY SA (BE) 2015-02-17 US disclosed
US-8877743-B2 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors NAEJA PHARMACEUTICAL INC. (CA) 2014-11-04 US disclosed
US-8871947-B2 Preparation of alkyl 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ester KingChem LLC (US) 2014-10-28 US disclosed
CN-104105684-A Preparation of alkyl 3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid ester KingChem LLC 2014-10-15 CN disclosed
US-20140288051-A1 BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETA-LACTAMASE INHIBITORS FEDORA PHARMACEUTICALS INC. (CA) 2014-09-25 US disclosed
US-20140221341-A1 BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETALACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC. (CA) 2014-08-07 US disclosed
WO-2014120397-A1 PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ESTER KINGCHEM, LLC (US) 2014-08-07 WO disclosed
US-20140221669-A1 PREPARATION OF ALKYL 3-DIFLUOROMETHYL-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ESTER KingChem LLC 2014-08-07 US disclosed
US-8796257-B2 Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors NAEJA PHARMACEUTICAL INC. (CA) 2014-08-05 US disclosed
WO-2014091268-A1 NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC. (CA) 2014-06-19 WO disclosed
US-20140120158-A1 Compositions and Methods for the Treatment of Parkinson Disease by the Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types PALOMO LIMITED (CY) 2014-05-01 US disclosed
US-20140051892-A1 Process for chemical synthesis from an alkenone made from a halogenated precursor SOLVAY SA (BE) 2014-02-20 US disclosed
US-20130281359-A1 NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETA-LACTAMASE INHIBITORS FEDORA PHARMACEUTICALS INC. (CA) 2013-10-24 US disclosed
US-20130225554-A1 NEW BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND BETA-LACTAMASE INHIBITORS NAEJA PHARMACEUTICAL INC. (CA) 2013-08-29 US disclosed
CN-101072758-B Quinazoline derivatives ASTRAZENECA AB 2013-07-31 CN disclosed
US-20120322991-A1 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types NLIFE THERAPEUTICS, S.L. (ES) 2012-12-20 US disclosed
EP-1871753-B1 PREPARATION OF TAXANES FROM 9-DIHYDRO-13-ACETYLBACCATIN III ACCORD HEALTHCARE INC (CA) 2012-07-18 EP disclosed
US-20120165351-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2012-06-28 US disclosed
US-8206914-B2 Evolving new molecular function PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-26 US disclosed
US-8153643-B2 Quinazoline derivatives ASTRAZENECA AB (SE) 2012-04-10 US disclosed
EP-1441011-B1 Energy transfer dye containing an aromatic-substituted xanthene dye as donor dye and/or acceptor dye LIFE TECHNOLOGIES CORP (US) 2012-02-22 EP disclosed
EP-1802591-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2012-01-11 EP disclosed
US-20110190141-A1 Evolving New Molecular Function PRESIDENT AND FELLOWS OF HAVARD COLLEGE (US) 2011-08-04 US disclosed
US-7771935-B2 Evolving new molecular function PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-08-10 US disclosed
CN-101245030-B Process for producing 1,2-bis(2,4-diaminophenyloxy)benzene UNIV DONGHUA 2010-06-30 CN disclosed
US-7667033-B2 Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis SYNGEN, INC. (US) 2010-02-23 US disclosed
US-20090233924-A1 Quinazoline derivatives ASTRAZENECA AB (SE) 2009-09-17 US disclosed
US-20090171076-A1 COMPOSITIONS AND METHODS FOR THE USE OF FMOC DERIVATIVES IN DNA/RNA SYNTHESIS SYNGEN, INC. 2009-07-02 US disclosed
CN-101367853-A 13-membered azalides and their use as antibiotic agents PFIZER PROD INC (US) 2009-02-18 CN disclosed
US-7491494-B2 Evolving new molecular function PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2009-02-17 US disclosed
CN-101245023-A Process for producing 2,2-bis[2,4-diaminophenyloxy)phenyl]hexafluoropropane UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245025-A Process for producing 1,3-bis(2,4-diaminophenyloxy)naphthalin UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245031-A Process for producing 1,2-bis(2,4-diaminophenyloxy)naphthalin UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245022-A Process for producing 3,5-bis(2,4-diaminophenyloxy)-2-naphthoic acid UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245026-A Process for producing 1,4-(2,4-diaminophenyloxy)-2,5-di-t-butyl benzene UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245024-A Process for producing 1,3-bis(2,4-diaminophenyloxy)benzene UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245028-A Process for producing 2,2-bis[3-amido-4-(4-aminophenoxy)phenyl] hexafluoropropane UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245030-A Process for producing 1,2-bis(2,4-diaminophenyloxy)benzene UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101245027-A Process for producing 2,2-bis[3-amido-4-(4-aminophenoxy)phenyl]propane UNIV DONGHUA (CN) 2008-08-20 CN disclosed
CN-101072758-A Quinazoline derivatives ASTRAZENECA AB (SE) 2007-11-14 CN disclosed
EP-1802591-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2007-07-04 EP disclosed
US-7179906-B2 Asymmetric benzoxanthene dyes APPLERA CORPORATION (US) 2007-02-20 US disclosed
EP-1540013-A4 EVOLVING NEW MOLECULAR FUNCTION HARVARD COLLEGE (US) 2006-06-28 EP disclosed
WO-2006040520-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2006-04-20 WO disclosed
US-20050170376-A1 Evolving new molecular function PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2005-08-04 US disclosed
EP-1540013-A2 EVOLVING NEW MOLECULAR FUNCTION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2005-06-15 EP disclosed
US-20050107617-A1 Mobility-modifying cyanine dyes APPLERA CORPORATION (US) 2005-05-19 US disclosed
US-20040225119-A1 Fluorescent dyes for use as diagnostic/signalling tool in nucleotide sequence analysis APPLERA CORPORATION (US) 2004-11-11 US disclosed
EP-0786468-B1 Solid support reagents for the direct synthesis of 3'-labeled polynucleotides APPLERA CORP (US) 2004-10-13 EP disclosed
US-20040180412-A1 Evolving new molecular function THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2004-09-16 US disclosed
EP-1244749-B1 MOBILITY-MODIFYING CYANINE DYES APPLERA CORP (US) 2004-09-01 EP disclosed
EP-1441011-A1 Energy transfer dye containing an aromatic-substituted xanthene dye as donor dye and/or acceptor dye Applera Corporation (US) 2004-07-28 EP disclosed
US-6716994-B1 FLUORESCENCE BASED FOUR COLOR NUCLEIC ACID SEQUENCING APPLERA CORPORATION 2004-04-06 US disclosed
EP-1019453-B1 AROMATIC-SUBSTITUTED XANTHENE DYES APPLERA CORP (US) 2004-03-31 EP disclosed
EP-1131331-B1 13-MEMBERED AZALIDES AND THEIR USE AS ANTIBIOTIC AGENTS PFIZER PROD INC (US) 2004-03-03 EP disclosed
WO-2004016767-A2 EVOLVING NEW MOLECULAR FUNCTION THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2004-02-26 WO disclosed
US-6673550-B2 PROBES FOR USE IN THE DETECTION AND MEASUREMENT OF PREFERENTIAL COMPOUND IN SAMPLE ACLARA BIOSCIENCES, INC. 2004-01-06 US disclosed
EP-0877751-B1 LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF UNIV TECHNOLOGIES INT (CA) 2003-10-15 EP disclosed
US-20030185878-A1 Process for producing phospholipid-containing drug TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
US-20030158245-A1 Fused heterocyclic derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-08-21 US disclosed
US-20030129593-A1 Process for producing multiple oligonucleotides on a solid support UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. 2003-07-10 US disclosed
EP-1293197-A1 PROCESS FOR PRODUCING PHOSPHOLIPID-CONTAINING DRUGS Takeda Chemical Industries, Ltd. (JP) 2003-03-19 EP disclosed
EP-1268486-A2 FUSED HETEROCYCLIC DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 2003-01-02 EP disclosed
US-20020146726-A1 Electrophoretic tag reagents comprising fluorescent compounds ACLARA BIOSCIENCES, INC. 2002-10-10 US disclosed
US-20020142329-A1 Compositions and methods employing cleavable electrophoretic tag reagents ACLARA BIOSCIENCES, INC. 2002-10-03 US disclosed
EP-1244749-A2 MOBILITY-MODIFYING CYANINE DYES Applera Corporation (US) 2002-10-02 EP disclosed
US-6348596-B1 NUCLEIC ACID HYBRIDIZATION ASSAYS; DNA SEQUENCE DETERMINATION PE CORPORATION (NY) 2002-02-19 US disclosed
CN-1326460-A Trideca-tertiary azalides and their use as antibiotics PFIZER PROD INC (US) 2001-12-12 CN disclosed
US-6329345-B1 13-membered azalides and their use as antibiotic agents PFIZER INC 2001-12-11 US disclosed
US-6303775-B1 POLYNUCLEOTIDE LABELED WITH SPECIFIC FLUORESCENT DYE; NONRADIOACTIVE ANALYSIS THE PERKIN-ELMER CORPORATION 2001-10-16 US disclosed
WO-2001074823-A2 FUSED HETEROCYCLIC DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-10-11 WO disclosed
EP-1131331-A1 13-MEMBERED AZALIDES AND THEIR USE AS ANTIBIOTIC AGENTS Pfizer Products Inc. (US) 2001-09-12 EP disclosed
WO-2001049790-A2 MOBILITY-MODIFYING CYANINE DYES APPLERA CORPORATION (US) 2001-07-12 WO disclosed
EP-1019453-A1 AROMATIC-SUBSTITUTED XANTHENE DYES THE PERKIN-ELMER CORPORATION (US) 2000-07-19 EP disclosed
WO-2000031097-A1 13-MEMBERED AZALIDES AND THEIR USE AS ANTIBIOTIC AGENTS PFIZER PRODUCTS INC. (US) 2000-06-02 WO disclosed
US-6020481-A FLUORESCENT LABELING REAGENTS; DIDEOXY POLYNUCLEOTIDE SEQUENCING AND FRAGMENT ANALYSIS METHODS. THE PERKIN-ELMER CORPORATION (US) 2000-02-01 US disclosed
US-6015895-A REACTING A LINKER COMPOUND WITH A HYDROXY GROUP OF A NUCLEOSIDE AND A SOLID SUPPORT CAPABLE OF ESTERIFICATION; LINKER IS STABILE AGAINST SPONTANEOUS HYDROLYSIS AND EASILY CLEAVED WHEN NECESSARY UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 2000-01-18 US disclosed
US-6008379-A USEFUL AS FLUORESCENT DYES FOR LABELING THE PERKIN-ELMER CORPORATION (US) 1999-12-28 US disclosed
EP-0891393-B1 ASYMMETRIC BENZOXANTHENE DYES PERKIN ELMER CORP (US) 1999-06-30 EP disclosed
WO-1999016832-A1 AROMATIC-SUBSTITUTED XANTHENE DYES THE PERKIN-ELMER CORPORATION (US) 1999-04-08 WO disclosed
EP-0891393-A1 ASYMMETRIC BENZOXANTHENE DYES THE PERKIN-ELMER CORPORATION (US) 1999-01-20 EP disclosed
US-5840999-A NAPHTHOL INTERMEDIATES FOR FLUORESCENT DYES THE PERKIN-ELMER CORPORATION (US) 1998-11-24 US disclosed
EP-0877751-A1 LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 1998-11-18 EP disclosed
US-5808039-A 2'-OMe CAC phosphoramidite and methods for preparation and use thereof BECKMAN INSTRUMENTS, INC. (US) 1998-09-15 US disclosed
US-5736626-A DIGLYCOLATE SYNTHESIS SUPPORTS THE PERKIN-ELMER CORPORATION (US) 1998-04-07 US disclosed
WO-1997036960-A1 ASYMMETRIC BENZOXANTHENE DYES THE PERKIN-ELMER CORPORATION (US) 1997-10-09 WO disclosed
EP-0786468-A2 Solid support reagents for the direct synthesis of 3'-labeled polynucleotides THE PERKIN-ELMER CORPORATION (US) 1997-07-30 EP disclosed
WO-1997023497-A1 LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) 1997-07-03 WO disclosed
US-5569769-A Preparation of pyrazole and its derivatives BASF AKTIENGESELLSCHAFT (DE) 1996-10-29 US disclosed
JP-H01156963-A PRODUCTION OF 1-SUBSTITUTED 5-AMINOPYRAZOLE UBE IND LTD 1989-06-20 JP disclosed
US-4013658-A SYNTHESIS OF 3,5-DIPHENYL-4(1H)-PYRIDAZINONES ELI LILLY AND COMPANY (US) 1977-03-22 US disclosed
US-4013658-A SYNTHESIS OF 3,5-DIPHENYL-4(1H)-PYRIDAZINONES ELI LILLY AND COMPANY (US) 1977-03-22 US disclosed